Siemens Healthineers (ETR:SHL) Given a €35.00 Price Target at Deutsche Bank

Deutsche Bank set a €35.00 ($40.70) price objective on Siemens Healthineers (ETR:SHL) in a research note released on Monday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Other equities research analysts have also issued research reports about the company. Goldman Sachs Group raised Altria Group from a neutral rating to a buy rating and set a $59.00 price target on the stock in a research note on Thursday, July 11th. JPMorgan Chase & Co. set a €33.40 ($38.84) price target on Siemens Healthineers and gave the stock a neutral rating in a research note on Thursday, July 11th. Nord/LB set a €90.00 ($104.65) price target on Henkel AG & Co KGaA and gave the stock a neutral rating in a research note on Tuesday, May 7th. Morgan Stanley boosted their price target on Visa from $175.00 to $191.00 and gave the stock an overweight rating in a research note on Thursday, July 11th. Finally, Jefferies Financial Group boosted their price target on Monster Beverage from $65.00 to $70.00 and gave the stock a buy rating in a research note on Friday, May 3rd. Fourteen investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Siemens Healthineers has an average rating of Hold and a consensus price target of €38.26 ($44.49).

Shares of ETR:SHL opened at €35.85 ($41.68) on Monday. The stock’s 50 day moving average price is €36.68. The stock has a market cap of $35.68 billion and a price-to-earnings ratio of 26.16. The company has a debt-to-equity ratio of 51.25, a current ratio of 1.31 and a quick ratio of 0.83. Siemens Healthineers has a 12 month low of €31.90 ($37.09) and a 12 month high of €39.95 ($46.45).

About Siemens Healthineers

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Further Reading: Trade Deficit

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.